REG - BSF Enterprise PLC - World First T-Rex Leather™ Product

BSF EnterpriseAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260402:nRSB1576Za&default-theme=true

RNS Number : 1576Z  BSF Enterprise PLC  02 April 2026

2 April 2026

 

BSF Enterprise PLC

 

Unveiling of World's First T-Rex Leather™ Product
and Commercialisation Roadmap

 

BSF Enterprise PLC (LSE: BSFA; OTCQB: BSFAF), a leader in the field of
lab-grown tissues and sustainable biotechnology, is pleased to announce the
unveiling of the world's first product made from lab-grown T-Rex Leather™
via its wholly owned subsidiary Lab-Grown Leather Ltd

 

The product, a one-of-a-kind luxury handbag designed by the avant-garde
techwear label Enfin Levé, will be debuted today at the Art Zoo Museum in
Amsterdam. The unveiling marks a significant milestone for BSF's wholly owned
subsidiary, Lab-Grown Leather Ltd., demonstrating the successful application
of its proprietary tissue engineering technology to extinct protein sequences.

 

Technological Breakthrough

T-Rex Leather™, an LGL proprietary material forming part of its Elemental
Leather™ range, was developed through a unique scientific collaboration
between Lab-Grown Leather Ltd., The Organoid Company, with the marketing
support of  creative agency VML.

 

●    Reconstruction: Scientists used AI-driven computational modelling to
reconstruct complete collagen blueprints from fossilised T.rex sequences.
Collagen being the principal structural element preserved in skin during the
formation of leather.

●    Cultivation: Using Lab-Grown Leather's Advanced Tissue Engineering
Platform (ATEP™), which underpins Elemental Leather™, billions of
engineered cells were cultivated to create a uniquely novel material based
upon predicted prehistoric genomic information. This innovative platform
facilitates the production of  a new class of bio-material, offering unique
aesthetics and feel not seen for 68 million years, whilst retaining
structural properties  found in traditional leather but without the need for
animal slaughter or synthetic scaffolds.

●    Sustainability: The resulting biomaterial is durable, repairable,
biodegradable, and compatible with existing leather finishing techniques.

 

Commercialisation and Market Strategy

While the initial handbag serves as a high-profile proof-of-concept, the
Company intends to scale the underlying technology across multiple high-value
sectors:

 

●    Luxury Fashion: T-Rex Leather™ will be made commercially available
to premium brands and designers for use in luxury accessories.

●    Automotive & Performance: Long-term ambitions include providing
high-performance, slaughter-free interiors for the automotive sector and other
high-performance material markets.

●    Market Opportunity: The Company is positioning its core product
Elemental Leather™ portfolio to capture share in the $60 billion luxury
leather market and the $20 billion bio-based materials market.

Upcoming Auction

Following a six-week exhibition at the Art Zoo Museum, the one-of-a-kind T-Rex
Leather™ handbag will be sold to the highest bidder. The Company expects the
auction to be conducted via a major international auction house later this
year. Further details regarding the auction partner and date will be released
in due course.

 

Dr Che Connon, commented:

 

"By collaborating with VML and The Organoid Company, we're unlocking the
potential to engineer leather from prehistoric species. This venture showcases
the power of cell-based technology to create materials that are both
innovative and ethically sound, paving the way for commercially attractive
improvements in unique character and cost-efficiency".

 

END

 

Engage with the BSF Enterprise management team directly by asking questions,
watching video

summaries and seeing what other shareholders have to say. Navigate to our
Interactive Investor

website here:

 

https://bsfenterprise.com/about

 

For further enquiries, please visit www.bsfenterprise.com
(http://www.bsfenterprise.com) or contact:

 

 BSF Enterprise PLC                                                           https://bsfenterprise.com/s/a1f22b (https://bsfenterprise.com/s/a1f22b)

 Geoff Baker - Chairman

 Che Connon - CEO & Director

 We encourage all investors to share questions on this announcement via our
 investor website.
 Shard Capital (Broker)

 Damon Heath                                                                  (0)20 4530 6926

 Isabella Pierre                                                              (0)20 4530 6928
 Bowsprit Partners

 John Treacy                                                                  +44 (0)203 883 4430

 James Sheehan
 ISIN of the Ordinary Shares

 is GB00BHNBDQ51.

 SEDOL Code is BHNBDQ5.

 

 

 

Subscribe to our news alert service: https://bsfenterprise.com/s/bb9f43
(https://bsfenterprise.com/s/bb9f43)

 

About BSF Enterprise PLC

BSF Enterprise PLC (LSE:BSFA) develops and commercialises cutting-edge
tissue-engineered solutions, including lab-grown leather (via LGL), cultivated
meat, and corneal repair technologies. By leveraging its proprietary
scaffold-free ATEP™ platform, BSF delivers sustainable, high-performance
alternatives to conventional materials, targeting global markets where
provenance, ethics, and performance are increasingly prized by consumers and
brands alike.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDAKDBQKBKBDQK



            Copyright 2019 Regulatory News Service, all rights reserved